Evidence map›Paper›PMID 37894901›Full record

ReviewInternational journal of molecular sciences2023

Engineering and Expression Strategies for Optimization of L-Asparaginase Development and Production.

Anastasiya N Shishparenok, Yulia A Gladilina, Dmitry D Zhdanov

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Secretory Expression ofJournal of microbiology and biotechnology · 2025
    Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Current pharmaceutical biotechnology · 2025
    Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Anastasiya N ShishparenokLaboratory of Medical Biotechnology, Institute of Biomedical Chemistry, Pogodinskaya St. 10/8, 119121 Moscow, Russia.
Yulia A GladilinaLaboratory of Medical Biotechnology, Institute of Biomedical Chemistry, Pogodinskaya St. 10/8, 119121 Moscow, Russia.
Dmitry D ZhdanovLaboratory of Medical Biotechnology, Institute of Biomedical Chemistry, Pogodinskaya St. 10/8, 119121 Moscow, Russia.ORCID 0000-0003-4753-7588
Institute of Biomedical Chemistry · RUPeoples' Friendship University of Russia · RU

Funding

Ministry of Education and Science of the Russian Federation 075-15-2021-933
6 · The paper itself

Abstract

Genetic engineering for heterologous expression has advanced in recent years. Model systems such as

Indexed as

Antineoplastic AgentsLeukemiaAsparaginaseAsparagineEscherichia coliHumansModels, BiologicalAntineoplastic AgentsAsparaginaseAsparaginecomputer design of enzymedirected evolutiongenetic engineeringheterologous expressionL-asparaginaserational design

Identifiers

PMID37894901
PMCPMC10607044
OpenAlexW4387687347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.